These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 2064956)

  • 1. Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood).
    Eden OB; Lilleyman JS; Richards S; Shaw MP; Peto J
    Br J Haematol; 1991 Jun; 78(2):187-96. PubMed ID: 2064956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials. UK Medical Research Council's Working Party on Childhood Leukaemia.
    Hann I; Vora A; Richards S; Hill F; Gibson B; Lilleyman J; Kinsey S; Mitchell C; Eden OB
    Leukemia; 2000 Mar; 14(3):356-63. PubMed ID: 10720126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved survival with early intensification: combined results from the Medical Research Council childhood ALL randomised trials, UKALL X and UKALL XI. Medical Research Council Working Party on Childhood Leukaemia.
    Richards S; Burrett J; Hann I; Chessells J; Hill F; Bailey C
    Leukemia; 1998 Jul; 12(7):1031-6. PubMed ID: 9665186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of Medical Research Council trial UKALL IX in acute lymphoblastic leukaemia in adults: report from the Medical Research Council Working Party on Adult Leukaemia.
    Durrant IJ; Richards SM
    Br J Haematol; 1993 Sep; 85(1):84-92. PubMed ID: 8251413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG).
    van der Does-van den Berg A; van Wering ER; Suciu S; Solbu G; van 't Veer MB; Rammeloo JA; de Koning J; van Zanen GE
    Am J Pediatr Hematol Oncol; 1989; 11(2):125-33. PubMed ID: 2665546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia.
    Chessells JM; Bailey C; Richards SM
    Lancet; 1995 Jan; 345(8943):143-8. PubMed ID: 7823668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol.
    Hann I; Vora A; Harrison G; Harrison C; Eden O; Hill F; Gibson B; Richards S;
    Br J Haematol; 2001 Apr; 113(1):103-14. PubMed ID: 11328289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRC UKALL X. The UK protocol for childhood ALL: 1985-1990. The Medical Research Council Working Party on Childhood Leukaemia.
    Chessells JM; Bailey CC; Richards S
    Leukemia; 1992; 6 Suppl 2():157-61. PubMed ID: 1578921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical Research Council leukaemia trial--UKALL V: an attempt to reduce the immunosuppressive effects of therapy in childhood acute lymphoblastic leukemia. Report to the Council by the Working Party on Leukaemia in Childhood.
    Chessells JM; Durrant J; Hardy RM; Richards S
    J Clin Oncol; 1986 Dec; 4(12):1758-64. PubMed ID: 3537216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Children under two years treated according to the Medical Research Council UKALL VIII study and trial 1980-1984 (on behalf of the Medical Research Council Working Party on Leukaemia in Childhood).
    Eden OB; Shaw MP; Lilleyman JS; Richards S
    Br J Cancer Suppl; 1992 Aug; 18():S58-62. PubMed ID: 1503928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial.
    Vora A; Goulden N; Mitchell C; Hancock J; Hough R; Rowntree C; Moorman AV; Wade R
    Lancet Oncol; 2014 Jul; 15(8):809-18. PubMed ID: 24924991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement in treatment for children with acute lymphoblastic leukaemia. The Medical Research Council UKALL trials, 1972-84. Report to the Council by the Working Party on Leukaemia in Childhood.
    Lancet; 1986 Feb; 1(8478):408-11. PubMed ID: 2868339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of advanced stage T cell lymphoblastic lymphoma: results of the United Kingdom Children's Cancer Study Group (UKCCSG) protocol 8503.
    Eden OB; Hann I; Imeson J; Cotterill S; Gerrard M; Pinkerton CR
    Br J Haematol; 1992 Oct; 82(2):310-6. PubMed ID: 1419812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of a new protocol to improve treatment results in paediatric lymphoblastic leukaemia: lessons from the UK Medical Research Council trials UKALL X and UKALL XI.
    Chessells JM; Harrison G; Richards SM; Gibson BE; Bailey CC; Hill FG; Hann IM;
    Br J Haematol; 2002 Aug; 118(2):445-55. PubMed ID: 12139731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica.
    Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi AM; Messina C; Mori PG; Miniero R; Colella R; Basso G
    J Clin Oncol; 1995 Oct; 13(10):2497-502. PubMed ID: 7595699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the immunophenotype of children treated on the Medical Research Council United Kingdom Acute Lymphoblastic Leukaemia Trial XI (MRC UKALLXI). Medical Research Council Childhood Leukaemia Working Party.
    Hann IM; Richards SM; Eden OB; Hill FG
    Leukemia; 1998 Aug; 12(8):1249-55. PubMed ID: 9697880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of childhood acute lymphoblastic leukemia: randomized trials of protocols CCLSG-L 841 and I 841. (Phase III study). Children's Cancer and Leukemia Study Group].
    Rinsho Ketsueki; 1989 Jul; 30(7):967-74. PubMed ID: 2681882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Childhood acute lymphoblastic leukaemia: outcomes of 54 consecutive patients treated in Auckland 1985-1991.
    Mauger DC; Skeen JE
    N Z Med J; 1998 Nov; 111(1078):454-6. PubMed ID: 9891565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early response to induction is predictive of survival in childhood Philadelphia chromosome positive acute lymphoblastic leukaemia: results of the Medical Research Council ALL 97 trial.
    Roy A; Bradburn M; Moorman AV; Burrett J; Love S; Kinsey SE; Mitchell C; Vora A; Eden T; Lilleyman JS; Hann I; Saha V;
    Br J Haematol; 2005 Apr; 129(1):35-44. PubMed ID: 15801953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes and prognostic factors of Chinese children with acute lymphoblastic leukemia in Hong Kong: preliminary results.
    Shing MM; Li CK; Chik KW; Lam TK; Lai HD; Ng MH; Cheung AY; Yuen PM
    Med Pediatr Oncol; 1999 Feb; 32(2):117-23. PubMed ID: 9950200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.